For the NIH, President Obama’s first term brought a funding windfall. Now its director, Francis Collins, faces a tightening budget.
When physician and geneticist Francis Collins took the helm of the US National Institutes of Health (NIH) in August 2009, the agency was flush with a one-time, US$8.2-billion injection of research funds from the American Recovery and Reinvestment Act. Since then, Collins, who headed the Human Genome Project, has had to fit his considerable ambitions to a stagnating NIH budget. He spoke to Nature about his time guiding the $31-billion agency. (...) - by Meredith Wadman, Nature, 26 September 2012